no code implementations • 26 Sep 2023 • Farzad Fatehi, Reidun Twarock
Protein nanoparticles play pivotal roles in many areas of bionanotechnology, including drug delivery, vaccination and diagnostics.
no code implementations • 4 Aug 2021 • Farzad Fatehi, Richard J. Bingham, Eric C. Dykeman, Peter G. Stockley, Reidun Twarock
A comparison of different treatment options in the context of this model reveals that drugs targeting aspects of the viral life cycle are more effective than exhaustion therapy, a form of therapy mitigating immune response exhaustion.
no code implementations • 4 Aug 2021 • Farzad Fatehi, Richard J. Bingham, Pierre-Philippe Dechant, Peter G. Stockley, Reidun Twarock
Defective interfering particles arise spontaneously during a viral infection as mutants lacking essential parts of the viral genome.
no code implementations • 18 Oct 2020 • Farzad Fatehi, Richard J Bingham, Eric C Dykeman, Peter G Stockley, Reidun Twarock
Within-host models of COVID-19 infection dynamics enable the merits of different forms of antiviral therapy to be assessed in individual patients.
no code implementations • 6 Jun 2020 • Nicola Bellomo, Richard Bingham, Mark A. J. Chaplain, Giovanni Dosi, Guido Forni, Damian A. Knopoff, John Lowengrub, Reidun Twarock, Maria Enrica Virgillito
This paper is devoted to the multidisciplinary modelling of a pandemic initiated by an aggressive virus, specifically the so-called \textit{SARS--CoV--2 Severe Acute Respiratory Syndrome, corona virus n. 2}.